|
1
|
Fukuda T, Fukui M, Tanaka M, Senmaru T,
Iwase H, Yamazaki M, Aoi W, Inui T, Nakamura N and Marunaka Y:
Effect of Brazilian green propolis in patients with type 2
diabetes: A double-blind randomized placebo-controlled study.
Biomed Rep. 3:355–360. 2015.PubMed/NCBI
|
|
2
|
Han L, Tang L, Wang C, Chen Z, Zhang T,
Chen S, Liu S, Peng X, Mai Y and Duan S: Fat mass and
obesity-associated gene rs11642015 polymorphism is significantly
associated with prediabetes and type 2 diabetes subsequent to
adjustment for body mass index. Biomed Rep. 2:681–686.
2014.PubMed/NCBI
|
|
3
|
Staimez LR, Weber MB, Narayan KM and
Oza-Frank R: A systematic review of overweight, obesity, and type 2
diabetes among Asian American subgroups. Curr Diabetes Rev.
9:312–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamada Y, Matsui K, Takeuchi I, Oguri M
and Fujimaki T: Association of genetic variants of the α-kinase 1
gene with type 2 diabetes mellitus in a longitudinal
population-based genetic epidemiological study. Biomed Rep.
3:347–354. 2015.PubMed/NCBI
|
|
5
|
Knabl J, Hüttenbrenner R, Hutter S,
Günthner-Biller M, Riedel C, Hiden U, Kainer F, Desoye G and
Jeschke U: Gestational diabetes mellitus upregulates vitamin D
receptor in extravillous trophoblasts and fetoplacental endothelial
cells. Reprod Sci. 22:358–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nicolucci A, Cercone S, Chiriatti A,
Muscas F and Gensini G: A Randomized trial on home telemonitoring
for the management of metabolic and cardiovascular risk in patients
with type 2 diabetes. Diabetes Technol Ther. 17:563–570. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu Y, Warren J, Walker N and Kennelly J:
Gender differences in cardiovascular disease risk management for
Pacific Islanders in primary care. Qual Prim Care. 21:275–285.
2013.PubMed/NCBI
|
|
8
|
Saisho Y: Glycemic variability and
oxidative stress: A link between diabetes and cardiovascular
disease? Int J Mol Sci. 15:18381–18406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Geetha R, Radika MK, Priyadarshini E,
Bhavani K and Anuradha CV: Troxerutin reverses fibrotic changes in
the myocardium of high-fat high-fructose diet-fed mice. Mol Cell
Biochem. 407:263–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu J, Wu DM, Zheng YL, Hu B, Cheng W,
Zhang ZF and Li MQ: Troxerutin counteracts domoic acid-induced
memory deficits in mice by inhibiting CCAAT/enhancer binding
protein β-mediated inflammatory response and oxidative stress. J
Immunol. 190:3466–3479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmeck-Lindenau HJ, Naser-Hijazi B,
Becker EW, Henneicke-von Zepelin HH and Schnitker J: Safety aspects
of a coumarin-troxerutin combination regarding liver function in a
double-blind placebo-controlled study. Int J Clin Pharmacol Ther.
41:193–199. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang ZF, Shan Q, Zhuang J, Zhang YQ, Wang
X, Fan SH, Lu J, Wu DM, Hu B and Zheng YL: Troxerutin inhibits
2,2′,4,4′-tetrabromodiphenyl ether (BDE-47)-induced hepatocyte
apoptosis by restoring proteasome function. Toxicol Lett.
233:246–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu X, Zhang Q, Cui W, Zeng Z, Yang W,
Zhang C, Zhao H, Gao W, Wang X and Luo D: Low molecular weight
fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki
rats by reducing oxidative stress and cardiomyocyte apoptosis. J
Diabetes Res. 2014:4209292014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Patel BM, Raghunathan S and Porwal U:
Cardioprotective effects of magnesium valproate in type 2 diabetes
mellitus. Eur J Pharmacol. 728:128–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stolen TO, Høydal MA, Kemi OJ, Catalucci
D, Ceci M, Aasum E, Larsen T, Rolim N, Condorelli G, Smith GL and
Wisløff U: Interval training normalizes cardiomyocyte function,
diastolic Ca2+ control and SR Ca2+ release synchronicity in a mouse
model of diabetic cardiomyopathy. Circ Res. 105:527–536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan HW, Xing SS, Bi XP, Li L, Gong HP,
Zhong M, Zhang Y and Zhang W: Felodipine attenuates vascular
inflammation in a fructose-induced rat model of metabolic syndrome
via the inhibition of NF-kappaB activation. Acta Pharmacol Sin.
29:1051–1059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Asare Y, Shagdarsuren E, Schmid JA,
Tilstam PV, Grommes J, El Bounkari O, Schütz AK, Weber C, de
Winther MP, Noels H and Bernhagen J: Endothelial CSN5 impairs NF-κB
activation and monocyte adhesion to endothelial cells and is highly
expressed in human atherosclerotic lesions. Thromb Haemost.
110:141–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hattori Y, Suzuki K, Tomizawa A, Hirama N,
Okayasu T, Hattori S, Satoh H, Akimoto K and Kasai K: Cilostazol
inhibits cytokine-induced nuclear factor-kappaB activation via
AMP-activated protein kinase activation in vascular endothelial
cells. Cardiovasc Res. 81:133–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Bei Y, Lu Y, Sun W, Liu Q, Wang Y,
Cao Y, Chen P, Xiao J and Kong X: Exercise prevents cardiac injury
and improves mitochondrial biogenesis in advanced diabetic
cardiomyopathy with PGC-1α and Akt activation. Cell Physiol
Biochem. 35:2159–2168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D,
Guo S, Ming Z and Liu C: Curcumin alleviates diabetic
cardiomyopathy in experimental diabetic rats. PLoS One.
7:e520132012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu Z, Ballou LM, Jiang YP, Cohen IS and
Lin RZ: Restoration of defective L-type Ca2+ current in cardiac
myocytes of type 2 diabetic db/db mice by Akt and PKC-i. J
Cardiovasc Pharmacol. 58:439–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Wu DM, Hu B, Zheng YL, Zhang ZF and
Wang YJ: NGF-Dependent activation of TrkA pathway: A mechanism for
the neuroprotective effect of troxerutin in D-galactose-treated
mice. Brain Pathol. 20:952–965. 2010.PubMed/NCBI
|
|
23
|
Lakshmanan AP, Harima M, Sukumaran V,
Soetikno V, Thandavarayan RA, Suzuki K, Kodama M, Nagata M, Takagi
R and Watanabe K: Modulation of AT-1R/AMPK-MAPK cascade plays
crucial role for the pathogenesis of diabetic cardiomyopathy in
transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats.
Biochem Pharmacol. 83:653–660. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reinking BE, Wedemeyer EW, Weiss RM, Segar
JL and Scholz TD: Cardiomyopathy in offspring of diabetic rats is
associated with activation of the MAPK and apoptotic pathways.
Cardiovasc Diabetol. 8:432009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gonzalez AB, Young L, Doll JA, Morgan GM,
Crawford SE and Plunkett BA: Elevated neonatal insulin-like growth
factor I is associated with fetal hypertrophic cardiomyopathy in
diabetic women. Am J Obstet Gynecol. 211:290 e1–e7. 2014.
View Article : Google Scholar
|
|
26
|
Sampath S and Karundevi B: Effect of
troxerutin on insulin signaling molecules in the gastrocnemius
muscle of high fat and sucrose-induced type-2 diabetic adult male
rat. Mol Cell Biochem. 395:11–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan Y, Wang Y, Zhao Y, Peng K, Li W, Wang
Y, Zhang J, Zhou S, Liu Q, Li X, et al: Inhibition of JNK
phosphorylation by a novel curcumin analog prevents high
glucose-induced inflammation and apoptosis in cardiomyocytes and
the development of diabetic cardiomyopathy. Diabetes. 63:3497–3511.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH
and Chen LM: Diallyl trisufide (DATS) suppresses high
glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB
signaling via attenuating ROS generation. Int J Cardiol.
168:270–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
